Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.33%
#3 Black Phoenix Black Phoenix +35.18%
#4 Velvet Velvet +25.69%
#5 Akedo Akedo +22.89%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#7 DoubleZero DoubleZero +17.26%
#8 Fake World Assets Fake World Assets +16.79%
#9 Palladium Network Palladium Network +14.94%
#10 clBTC clBTC +11.73%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Classement en actions #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Prix de l'action
$0.01904982
Dernière synchronisation: 2023-05-19
Capitalisation boursière
$316.00K
Changement (1 jour)
-17.05%
Changement (1 an)
0.00%
Pays
GB
Échange OKYO Pharma Limited (OKYO)

Catégorie

Healthcare
Ratio P/B pour OKYO Pharma Limited (OKYO)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de OKYO Pharma Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour OKYO Pharma Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE